Catalyst Wire Dossier Catalyst Wire Dossier

Nicotinamide Mononucleotide

nicotinamide mononucleotide
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Nicotinamide Mononucleotide, covering 2022-02-01 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults [NA]

See pricing